Pharmiva AB (publ) PHARM.ST Stock
0.56 SEK
{{ price }}
0.000000%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Sweden
Exchange
Stockholm
Market Cap
12.93M SEK
LOW - HIGH [24H]
0.0000
-
0.0000 SEK
VOLUME [24H]
0 SEK
{{ volume }}
P/E Ratio
0
Earnings per share
0 SEK
Pharmiva AB (publ) Price Chart
Pharmiva AB (publ) PHARM.ST Financial and Trading Overview
| Pharmiva AB (publ) stock price | 0.56 SEK |
| Previous Close | 1.01 SEK |
| Open | 0.98 SEK |
| Bid | 0.94 SEK x N/A |
| Ask | 0.97 SEK x N/A |
| Day's Range | 0.93 - 0.98 SEK |
| 52 Week Range | 0.67 - 4 SEK |
| Volume | 37.19K SEK |
| Avg. Volume | 45.47K SEK |
| Market Cap | 16.54M SEK |
| Beta (5Y Monthly) | 1.835694 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 SEK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PHARM.ST Valuation Measures
| Enterprise Value | 9.63M SEK |
| Trailing P/E | N/A |
| Forward P/E | -0.34 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 3.6484234 |
| Price/Book (mrq) | 0.76898223 |
| Enterprise Value/Revenue | 2.123 |
| Enterprise Value/EBITDA | -0.426 |
Trading Information
Pharmiva AB (publ) Stock Price History
| Beta (5Y Monthly) | 1.835694 |
| 52-Week Change | -71.92% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 4 SEK |
| 52 Week Low | 0.67 SEK |
| 50-Day Moving Average | 1.31 SEK |
| 200-Day Moving Average | 1.62 SEK |
PHARM.ST Share Statistics
| Avg. Volume (3 month) | 45.47K SEK |
| Avg. Daily Volume (10-Days) | 41.02K SEK |
| Shares Outstanding | 17.38M |
| Float | 17.31M |
| Short Ratio | N/A |
| % Held by Insiders | 45.63% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -502.86% |
| Gross Margin | 65.46% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -53.43% |
| Return on Equity (ttm) | -98.84% |
Income Statement
| Revenue (ttm) | 4.53M SEK |
| Revenue Per Share (ttm) | 0.37 SEK |
| Quarterly Revenue Growth (yoy) | 153.59% |
| Gross Profit (ttm) | 2.59M SEK |
| EBITDA | -22622000 SEK |
| Net Income Avi to Common (ttm) | -22802000 SEK |
| Diluted EPS (ttm) | -2.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.27M SEK |
| Total Cash Per Share (mrq) | 0.59 SEK |
| Total Debt (mrq) | 0 SEK |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.877 |
| Book Value Per Share (mrq) | 1.238 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22312000 SEK |
| Levered Free Cash Flow (ttm) | -15111250 SEK |
Profile of Pharmiva AB (publ)
| Country | Sweden |
| State | N/A |
| City | Lund |
| Address | Sankt Lars VAeg 45B |
| ZIP | 22270 |
| Phone | 46 4 62 86 51 00 |
| Website | https://www.pharmiva.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Pharmiva AB (publ) engages in the research and development of medical products. The company develops Vernivia, an over-the-counter vaginal mousse for the treatment of bacterial vaginosis. Pharmiva AB (publ) is based in Lund, Sweden.
Q&A For Pharmiva AB (publ) Stock
What is a current PHARM.ST stock price?
Pharmiva AB (publ) PHARM.ST stock price today per share is 0.56 SEK.
How to purchase Pharmiva AB (publ) stock?
You can buy PHARM.ST shares on the Stockholm exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pharmiva AB (publ)?
The stock symbol or ticker of Pharmiva AB (publ) is PHARM.ST.
Which industry does the Pharmiva AB (publ) company belong to?
The Pharmiva AB (publ) industry is Biotechnology.
How many shares does Pharmiva AB (publ) have in circulation?
The max supply of Pharmiva AB (publ) shares is 23.09M.
What is Pharmiva AB (publ) Price to Earnings Ratio (PE Ratio)?
Pharmiva AB (publ) PE Ratio is 0.00000000 now.
What was Pharmiva AB (publ) earnings per share over the trailing 12 months (TTM)?
Pharmiva AB (publ) EPS is 0 SEK over the trailing 12 months.
Which sector does the Pharmiva AB (publ) company belong to?
The Pharmiva AB (publ) sector is Healthcare.
Pharmiva AB (publ) PHARM.ST included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| First North Sweden SEK PI FNSESEKPI | 1843.91 SEK 179.99 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR PI FNSEEURPI | 1479.5 EUR 1617.29 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care PI FN20PI | 912.9 EUR 997.92 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share SEK FIRSTNORTHSEK | 123.34 SEK 12.04 USD |
-0.14
|
— — | — — | — — | — - | — — |
| First North All-Share DKK FIRSTNORTHDKK | 97.96 DKK 14.36 USD |
-0.62
|
— — | — — | — — | — - | — — |
| First North Sweden SEK GI FNSESEKGI | 1956.89 SEK 191.02 USD |
-0.28
|
— — | — — | — — | — - | — — |
| First North Sweden EUR GI FNSEEURGI | 1570.14 EUR 1716.38 USD |
-0.77
|
— — | — — | — — | — - | — — |
| First North Health Care GI FN20GI | 917.04 EUR 1002.44 USD |
-1.17
|
— — | — — | — — | — - | — — |
| First North All-Share EUR FIRSTNORTHEUR | 97.9 EUR 107.01 USD |
-0.64
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}